EE530 Cost Per Response, Remission and Endoscopic Improvement of Advanced Therapies of Bio-Exposed Patients With Moderately-to-Severely Active Ulcerative Colitis (UC) in France
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.771
https://www.valueinhealthjournal.com/article/S1098-3015(22)02975-8/fulltext
Title :
EE530 Cost Per Response, Remission and Endoscopic Improvement of Advanced Therapies of Bio-Exposed Patients With Moderately-to-Severely Active Ulcerative Colitis (UC) in France
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02975-8&doi=10.1016/j.jval.2022.09.771
First page :
Section Title :
Open access? :
No
Section Order :
10317